Sentences with phrase «tested on cancer»

Historically, a potential therapeutic compound would be tested on cancer cell lines to validate the functional efficacy of the compound.

In the early 1990s, in vitro tests on cancer cells by Lane and his colleagues hinted that some compounds could restore mutant p53's normal function.

The team is now calling for a much larger clinical trial, involving one quarter of a million women, to investigate the effect of the screening using HPV testing on cancer rates.

The Houston - based company Nanospectra has licensed the treatment, and company president Don Payne expects to begin testing it on cancer patients within a year.

The first tests on these cancer specimens were performed in our lab and we found that 93 percent of all cervical cancers had HPV.

Not exact matches

Darzalex, however, has not yet reached its peak potential as the drug moves into earlier stages of the disease and is being tested on solid tumours like lung cancer.

«Color's $ 99 BRCA Test, the most affordable genetic test for BRCA1 and BRCA2 ever on the market, is now available to any woman who wants to take the first step toward learning her risk for hereditary breast and ovarian cancer,» said the company in a blog pTest, the most affordable genetic test for BRCA1 and BRCA2 ever on the market, is now available to any woman who wants to take the first step toward learning her risk for hereditary breast and ovarian cancer,» said the company in a blog ptest for BRCA1 and BRCA2 ever on the market, is now available to any woman who wants to take the first step toward learning her risk for hereditary breast and ovarian cancer,» said the company in a blog post.

The company has performed thousands of tests and is working on detecting prostate, breast, colon, and lung cancers.

When Theranos came to its headquarters to do blood tests on employees, for instance, one received a frighteningly high result that suggested the executive had prostate cancer.

«We look forward to a day in the not too distant future where there would be a simple blood test for every form of cancer,» Dr. Richard Klausner, former director of the National Cancer Institute and a board member of Grail, said on a press call on Scancer,» Dr. Richard Klausner, former director of the National Cancer Institute and a board member of Grail, said on a press call on SCancer Institute and a board member of Grail, said on a press call on Sunday.

For example, labs take DNA samples from patients being tested for cancer and runs tests to detect if mutations typically associated with cancer are present; a diagnostician then examines those genetic mutations and compares them to known instances; finally, based on that information a physician recommends a course of treatment.

At last year's Brainstorm Health conference in San Diego, Bergh found himself sitting at dinner with Othman Laraki, the cofounder and CEO of Color Genomics — a company that extracts the DNA from a customer's submitted saliva sample and then looks for a set number of gene mutations known to be associated with increased risk for developing certain hereditary cancers or heart conditions (depending on the test).

The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.

The medicines, which help unleash the immune system on cancer cells, were tested in patients with advanced lung cancer.

In the last of those years, the reporters discovered, the federal government actually spent more on urine - based drug tests than it did on «the four most recommended cancer screenings combined.»

The study, just published in Science, showed that the creation of what the researchers are calling microtumors can help predict drug effectiveness in cancer patients better than the current standard method of testing the drugs on rodents.

Dimon, who is the longest - serving CEO of the major banks, said that he had undergone tests including a CAT scan, PET scan and a biopsy, which showed that the cancer is confined to the throat and the adjacent lymph nodes on the right side of his neck.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

In 2000, Medarex began its first phase of human testing on its new «CTLA -4-blockade» — in patients who had either prostate cancer or metastatic melanoma, a deadly form of skin cancer.

I think in 10 years, we'll have cancer tests such that you take them once or twice a year, find out you have early - stage cancer, take care of it early, and move on.

On the fifth spot is Counsyl, which provides cheap DNA tests for would - be parents and cancer screening.

Indeed, the 25 - person company has now tested thousands of blood samples, and it says its tests outperform current screening tests on the market for four types of cancer: prostate, breast, colorectal, and lung.

New York, Wall Street Journal — Genomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new - generation drugs or rely on much cheaper traditional chemotherapy to improve their chances for survival.

Interest on cancer blood tests remains on the rise, which investors pitching millions to create them.

Drug developer Loxo Oncology said on Tuesday it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.

April 10 Drug developer Loxo Oncology said on Tuesday it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.

On the other hand, such tests do catch cancer and sometimes save lives.

athe fact that we can not test a cancer medication on the exact same sample doesn't stop us fro calling it good enough.

It's only been tested on mice so far, but the results are tremendously promising for an antibody Stanford researchers have been experimenting with that blocks the body from «eating» cancer cells.

Believe it or not, the ultra liberal look just as foolish (seriously: set the lab mice we are testing cancer treatments on free, but kill the unborn children because their mothers deserve not to have their lives ruined by stressful bundles of joy)

Not long after, I found myself at a cancer center looking over an oncologist's shoulder and examining my test results on his computer.

Do you also want to allow a vegan - owned or religious group opposed to animal testing to force people to pay for any cancer treatment tested on animals?

Nope, that is why we have an over abundance of children in cancer hospitals being treated on a daily basis because we are being tested by God.

Scientists have been sounding the alarm on the danger of glyphosate for years now, but it has apparently taken a report from the World Health Organization last year stating that the science on glyphosate shows it is likely linked to cancer, to get the FDA to finally start testing American food for glyphosate.

In a letter to OEHHA opposing the listing of 4 - MEI, Dr. Ernest E. McConnell, former Director of the National Toxicology Program's Toxicology Research and Testing Program, wrote: «NTP has not included 4 - MEI on its list of chemicals causing cancer; i.e., the Report on Carcinogens.»

Both of these symptoms are potential signs of leukemia, a type of cancer of the blood or bone marrow, and tests conducted last week, while the Colts were on a bye, confirmed the specific diagnosis of APL.

An expert weighs in on factors to be considered when making difficult decisions regarding testing for breast cancer.

When possible, the preference is to obtain genetic testing on the person with cancer before testing other family members.

Her work in systematic reviews has consistently addressed tough topics and has included documenting harms of episiotomy, the limitations of data about outcomes of fetal surgery, inconsistencies in results of programs designed to reduce use of cesarean, marginal effectiveness of medications for overactive bladder, and the burden on cervical cancer prevention programs introduced by liquid cytology collection for pap testing.

But then again, the thousands of false positives on a cancer screening also suffer in some ways, the emotional stress, the follow - up testing, etc..

The mayor's office released no information on symptoms Maggie Daley may have exhibited that led to the testing, the type of cancer detected, its extent, or the type of treatment she will receive.

Colon cancer test Non-invasive, virtual colonoscopies — which involve a CT scan of the lower body — are as effective as standard colonoscopies at detecting large and medium - size polyps that can lead to colon cancer, according to the largest and most definitive study to date on the controversial technology.

These internal medicine doctors who focus solely on caring for people with breast cancer and other breast conditions will meet with you to understand your needs and make arrangements for necessary tests and appointments.

You might need a Pap test to screen for cervical cancer as well, depending on how long it's been since your last screening.

We're still waiting on a couple of tests to come back: some more hormone tests (my cancer is 95 % responsive to estrogen), and some genetic testing, but basically he told me that my cancer is very cooperative, it hasn't spread, and there is very little chance that I will need a mastectomy or chemotherapy.

Scientists have linked low doses of BPA to obesity, diabetes, thyroid disease, breast cancer, prostate cancer and other illnesses in lab tests on animals.

«It's unacceptable that women are forced to put their lives on hold as they wait so long to get these vital test results,» said Jeremy Hughes, chief executive of Breakthrough Breast Cancer.

He said restrictions on federal dollars to fund breast cancer screenings and STD tests, among other things, are also unconstitutional.

He battled cancer and went on to pass one of the most gruelling physical tests in the sporting world.

The Bill - which was passed by the House of Lords - would have allowed doctors to test cutting edge new treatments on patients to help find cures for cancer and other serious illnesses.